US11708377B2ActiveUtilityA1
Analogues and derivatives of cephalotaxine and methods for making and using the compounds
Est. expiryMar 11, 2039(~12.7 yrs left)· nominal 20-yr term from priority
C07D 498/06C07D 491/153C07D 498/18C07D 491/20
49
PatentIndex Score
0
Cited by
9
References
26
Claims
Abstract
Disclosed herein are embodiments of a compound having a Formula Ior a salt, solvate, N-oxide, prodrug, diastereomer or enantiomer thereof. Also disclosed are derivative compounds made from the compound of Formula I. Certain derivative compounds have a Formula V-2, or a salt, solvate, N-oxide, prodrug, diastereomer or enantiomer thereof.Also disclosed are method for making and using the disclosed compounds. Certain disclosed embodiments are useful for treating and/or preventing certain diseases and/or disorders, including proliferation diseases, such as leukemia.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A compound having a formula
or a salt, solvate, N-oxide, diastereomer or enantiomer thereof, wherein:
x is from 0 to 4;
each R 1 independently is hydroxyl, halogen, aliphatic, alkoxy, haloalkyl, amino, protected amino, carboxylic ester, or two R 1 s, together with the atoms to which they are attached, form an aryl or heterocyclyl;
each of R 2 , R 3 , R 4 and R 5 independently is H, halogen, aliphatic, hydroxyalkyl, protected hydroxyalkyl, aryl, heteroaryl, hydroxyl, protected hydroxyl, haloalkyl, amino, protected amino, carboxylic ester, or two of R 2 , R 3 , R 4 and R 5 that are attached to the same carbon together form ═O or ═S; and
each of Q 1 and Q 2 independently is aliphatic.
2. The compound of claim 1 , wherein x is 2, 3, or 4.
3. The compound of claim 1 , wherein two R 1 s together with the atoms to which they are attached, form an aryl or 5- or 6-membered heterocyclyl ring.
4. The compound of claim 3 , wherein the 5- or 6-membered heterocyclyl is a pyridinyl, imidazolyl, pyrazolyl, pyrrolyl, oxazolyl, thiazolyl, furanyl, thiophenyl, 1,3-dioxole, 1,4-dioxine, 2,3-dihydro-1,4-dioxine, 1,4-oxazine, or 3,4-dihydro-1,4-oxazine.
5. The compound of claim 1 , wherein the
moiety is
6. The compound of claim 1 , wherein the
moiety is
7. The compound of claim 1 , wherein each of Q 1 and Q 2 independently is alkyl optionally substituted with 1, 2, 3, or 4 substituents from halogen, alkyl, hydroxyalkyl, protected hydroxyalkyl, ═O, ═S, aryl, hydroxyl, protected hydroxyl, haloalkyl, amino, protected amino, or carboxylic ester.
8. The compound of claim 7 , wherein each of Q 1 and Q 2 independently is C 1-2 alkyl optionally substituted with 1, 2, 3, or 4 substituents from halogen, alkyl, hydroxyalkyl, protected hydroxyalkyl, ═O, ═S, aryl, hydroxyl, protected hydroxyl, haloalkyl, amino, protected amino, or carboxylic ester.
9. The compound of claim 8 ,
wherein one or more of the following applies:
i) Q 1 is —CH 2 — or —CH 2 CH 2 —;
ii) Q 2 is —CH 2 — or —CH 2 CH 2 ; or
iii) Q 1 is —CH 2 — or —CH 2 CH 2 — and Q 2 is —CH 2 — or —CH 2 CH 2 .
10. The compound of claim 8 , wherein one or both of the following applies:
Q 1 is substituted with 1, 2, 3, or 4 substituents from methyl, ethyl, ═O, ═S, hydroxyl, phenyl, hydroxyethyl, hydroxypropyl, protected hydroxyalkyl, protected hydroxyl, or protected amino;
Q 2 is substituted with 1, 2, 3, or 4 substituents from Cl, methyl, ethyl, ═O, ═S, hydroxyl, protected hydroxyl, hydroxyethyl, hydroxypropyl, protected hydroxyalkyl, protected hydroxyl, or protected amino.
11. The compound of claim 1 , wherein each of R 2 , R 3 , R 4 and R 5 independently is H, halogen, aliphatic, hydroxyalkyl, protected hydroxyalkyl, aryl, heteroaryl, hydroxyl, protected hydroxyl, or two of R 2 , R 3 , R 4 and R 5 that are attached to the same carbon together form ═O or ═S.
12. The compound of claim 1 , wherein each of R 2 , R 3 , R 4 and R 5 is H.
13. The compound of claim 1 , wherein the
moiety is
wherein PG is a hydroxyl protecting group.
14. The compound of claim 13 , wherein PG is methoxymethyl (MOM), tert-butyl, iso-propyl, tert-butyldimethylsilyl (TBS or TBDMS), trimethylsilyl (TMS), triethylsilyl (TES), tert-butyldiphenylsilyl (TBDPS), or triisopropylsilyl (TIPS).
15. The compound of claim 1 , wherein the
moiety is
wherein PG is a hydroxyl protecting group.
16. The compound of claim 15 , wherein PG is methoxymethyl (MOM), tert-butyl, iso-propyl, tert-butyldimethylsilyl (TBS or TBDMS), trimethylsilyl (TMS), triethylsilyl (TES), tert-butyldiphenylsilyl (TBDPS), or triisopropylsilyl (TIPS).
17. The compound of claim 1 , wherein the compound is
18. A method for making a compound of Formula I, comprising:
i) treating a protected hydroxyl ketone of formula A-1 with a haloacetate ester of formula A-2 to form a compound of formula A-3
ii) treating the compound of formula A-3 with a protected amino compound of formula A-4 to form a compound of formula A-5
iii) converting the OPG moiety of A-5 to a leaving group in a compound of formula A-6
and
iv) cyclizing A-6 to form the compound of Formula I,
or a salt, solvate, N-oxide, diastereomer or enantiomer thereof, wherein:
each PG independently is a protecting group;
LG is a leaving group;
each X 1 independently is a halogen;
x is from 0 to 4;
R A is alkyl;
if present, each R 1 independently is hydroxyl, halogen, aliphatic, alkoxy, haloalkyl, amino, protected amino, carboxylic ester, or two R 1 s, together with the atoms to which they are attached, form an aryl or heterocyclyl;
each of R 2 , R 3 , R 4 and R 5 independently is H, halogen, aliphatic, hydroxyalkyl, protected hydroxyalkyl, aryl, heteroaryl, hydroxyl, protected hydroxyl, haloalkyl, amino, protected amino, carboxylic ester, or two of R 2 , R 3 , R 4 and R 5 that are attached to the same carbon together form ═O or =S; and
each of Q 1 and Q 2 independently is aliphatic.
19. The method of claim 18 , wherein one or more of the following applies:
i) each PG independently is trifluoroacetate or a silyl protecting group;
ii) LG is mesylate;
iii) X 1 is Cl;
iv) R A is C 1-2 alkyl.
20. A method for making a compound of Formula (II), comprising:
treating a compound of Formula I
or a salt, solvate, N-oxide, diastereomer or enantiomer thereof, with an oxidizing agent to form a racemic compound of Formula II
or a salt, solvate, or N-oxide thereof, wherein:
x is from 0 to 4;
if present, each R 1 independently is hydroxyl, halogen, aliphatic, alkoxy, haloalkyl, amino, protected amino, carboxylic ester, or two R 1 s, together with the atoms to which they are attached, form an aryl or heterocyclyl;
each of R 2 , R 3 , R 4 and R 5 independently is H, halogen, aliphatic, hydroxyalkyl, protected hydroxyalkyl, aryl, heteroaryl, hydroxyl, protected hydroxyl, haloalkyl, amino, protected amino, carboxylic ester, or two of R 2 , R 3 , R 4 and R 5 that are attached to the same carbon together form ═O or =S; and
each of Q 1 and Q 2 independently is aliphatic.
21. The method of claim 20 , wherein the oxidizing agent is DDQ.
22. The method of claim 20 , further comprising:
treating the racemic compound of Formula II with Ru(p-cymene)-(S,S)-TsDPEN, trimethylamine, and formic acid to form a compound of Formula A-7 and a (+)-compound of Formula II
23. The method of claim 22 , further comprising treating the (+)-compound of Formula II with 2,2-dimethoxypropane and p-toluene sulfonic acid to form a second portion of racemic compound according to Formula II
24. The method of claim 22 , wherein the compound of formula I is
and the compound of formula A-7 is
25. The method of claim 18 , wherein R 2 , R 3 , R 4 , and R 5 are all H.
26. The method of claim 18 , wherein:
R 2 , R 3 , R 4 , and R 5 are all H;
Q 1 is —CH 2 CH 2 —;
Q 2 is —CH—;
the
moiety is
and
the compound of Formula I isCited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.